Crowdonomics
WatchlistPortfolio
All companies
Circle Medical Technologies, Inc. logo

Circle Medical Technologies, Inc.

Operating

Healthcare · San Francisco, CA

Visit website
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$6,112,858
Crowd $0 · Private $6.1M · 2 rounds since 2018
Latest share price
$0.7296
Reg CF Offering (2018) offering price

Financials

FY2016–FY2017 · from SEC filings · hover any figure for its source
$216K
−$1.8M
2016
$805K
−$1.9M
2017
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2016 reviewed*
FY2017 reviewed*
Income statement
Revenue
$215,506
$804,733
Cost of goods sold
$519,486
$1,066,502
Gross margin
-141%
-33%
Net income
-$1,785,533
-$1,907,499
Taxes paid
$3,368
$1,850
Balance sheet
Cash
$692,360
$1,153,920
Accounts receivable
$77,188
$155,815
Total assets
$821,399
$1,375,958
Short-term debt
$114,720
$99,320
Long-term debt
$2,942,942
$5,427,942
Total liabilities
$3,057,662
$5,527,262
Other
Headcount
—
13

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Reg CF · Preferred Stock · Sep 2018Closedvia WeFunder
Raised $0 / $1.1M
Rule 506(b) · Equity · Jul 2018Closed
Raised $6.1MInvestors 41

Team

2 people
George FavvasFounder
CEO and Co-founder
Jean-Sebastien BoulangerFounder
CTO and Co-founder

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

41 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C/AMar 19, 20190001670254-19-000118
    EDGAR
  • Form CSep 28, 20180001670254-18-000464
    EDGAR
  • Form DAug 9, 20180001748771-18-000002
    EDGAR
Source: SEC EDGARCIK 0001748771DEShare price $0.7296Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.